vs
爱德华生命科学（EW）与罗布乐思（RBLX）财务数据对比。点击上方公司名可切换其他公司
爱德华生命科学的季度营收约是罗布乐思的1.2倍（$1.6B vs $1.4B），爱德华生命科学净利率更高（23.1% vs -22.3%，领先45.4%），罗布乐思同比增速更快（43.2% vs 16.7%），过去两年罗布乐思的营收复合增速更高（32.9% vs 9.7%）
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
罗布乐思（Roblox Corporation）是总部位于美国加利福尼亚州圣马特奥的游戏企业，由大卫·巴斯祖奇与埃里克·卡塞尔于2004年共同创立。公司核心产品为同名线上游戏创作平台Roblox，于2006年正式上线，截至2024年12月底全球员工规模已超2400人。
EW vs RBLX — 直观对比
营收规模更大
EW
是对方的1.2倍
$1.4B
营收增速更快
RBLX
高出26.5%
16.7%
净利率更高
EW
高出45.4%
-22.3%
两年增速更快
RBLX
近两年复合增速
9.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.4B |
| 净利润 | $380.7M | $-316.0M |
| 毛利率 | 78.0% | 77.7% |
| 营业利润率 | 1.8% | -25.3% |
| 净利率 | 23.1% | -22.3% |
| 营收同比 | 16.7% | 43.2% |
| 净利润同比 | 6.8% | -43.9% |
| 每股收益（稀释后） | $0.66 | $-0.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EWRBLX
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $1.4B | ||
| Q3 25 | $1.6B | $1.4B | ||
| Q2 25 | $1.5B | $1.1B | ||
| Q1 25 | $1.4B | $1.0B | ||
| Q4 24 | $1.4B | $988.2M | ||
| Q3 24 | $1.4B | $919.0M | ||
| Q2 24 | $1.4B | $893.5M |
净利润EWRBLX
| Q1 26 | $380.7M | — | ||
| Q4 25 | $91.2M | $-316.0M | ||
| Q3 25 | $291.1M | $-255.6M | ||
| Q2 25 | $333.2M | $-278.4M | ||
| Q1 25 | $358.0M | $-215.1M | ||
| Q4 24 | $385.6M | $-219.6M | ||
| Q3 24 | $3.1B | $-239.3M | ||
| Q2 24 | $366.3M | $-205.9M |
毛利率EWRBLX
| Q1 26 | 78.0% | — | ||
| Q4 25 | 78.1% | 77.7% | ||
| Q3 25 | 77.8% | 78.2% | ||
| Q2 25 | 77.5% | 78.2% | ||
| Q1 25 | 78.7% | 78.3% | ||
| Q4 24 | 78.9% | 77.9% | ||
| Q3 24 | 80.6% | 77.7% | ||
| Q2 24 | 79.9% | 77.8% |
营业利润率EWRBLX
| Q1 26 | 1.8% | — | ||
| Q4 25 | 9.6% | -25.3% | ||
| Q3 25 | 19.8% | -21.8% | ||
| Q2 25 | 26.8% | -29.8% | ||
| Q1 25 | 27.9% | -24.6% | ||
| Q4 24 | 22.6% | -24.7% | ||
| Q3 24 | 25.9% | -30.4% | ||
| Q2 24 | 26.8% | -26.6% |
净利率EWRBLX
| Q1 26 | 23.1% | — | ||
| Q4 25 | 5.8% | -22.3% | ||
| Q3 25 | 18.7% | -18.8% | ||
| Q2 25 | 21.7% | -25.8% | ||
| Q1 25 | 25.3% | -20.8% | ||
| Q4 24 | 27.8% | -22.2% | ||
| Q3 24 | 226.7% | -26.0% | ||
| Q2 24 | 26.7% | -23.0% |
每股收益（稀释后）EWRBLX
| Q1 26 | $0.66 | — | ||
| Q4 25 | $0.16 | $-0.44 | ||
| Q3 25 | $0.50 | $-0.37 | ||
| Q2 25 | $0.56 | $-0.41 | ||
| Q1 25 | $0.61 | $-0.32 | ||
| Q4 24 | $0.65 | $-0.32 | ||
| Q3 24 | $5.13 | $-0.37 | ||
| Q2 24 | $0.61 | $-0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $3.1B |
| 总债务越低越好 | — | $1.2B |
| 股东权益账面价值 | — | $394.5M |
| 总资产 | — | $9.6B |
| 负债/权益比越低杠杆越低 | — | 2.98× |
8季度趋势，按日历期对齐
现金及短期投资EWRBLX
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | $3.1B | ||
| Q3 25 | $3.8B | $2.9B | ||
| Q2 25 | $4.1B | $2.6B | ||
| Q1 25 | $3.9B | $2.7B | ||
| Q4 24 | $4.0B | $2.4B | ||
| Q3 24 | $4.4B | $2.3B | ||
| Q2 24 | $2.0B | $2.4B |
总债务EWRBLX
| Q1 26 | — | — | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益EWRBLX
| Q1 26 | — | — | ||
| Q4 25 | $10.3B | $394.5M | ||
| Q3 25 | $10.2B | $407.6M | ||
| Q2 25 | $10.5B | $353.2M | ||
| Q1 25 | $10.1B | $310.7M | ||
| Q4 24 | $10.0B | $221.4M | ||
| Q3 24 | $9.5B | $189.9M | ||
| Q2 24 | $7.4B | $121.5M |
总资产EWRBLX
| Q1 26 | — | — | ||
| Q4 25 | $13.7B | $9.6B | ||
| Q3 25 | $13.3B | $8.6B | ||
| Q2 25 | $13.5B | $7.8B | ||
| Q1 25 | $13.0B | $7.5B | ||
| Q4 24 | $13.1B | $7.2B | ||
| Q3 24 | $13.0B | $6.7B | ||
| Q2 24 | $10.1B | $6.5B |
负债/权益比EWRBLX
| Q1 26 | — | — | ||
| Q4 25 | — | 2.98× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 5.48× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $607.0M |
| 自由现金流经营现金流 - 资本支出 | — | $308.6M |
| 自由现金流率自由现金流/营收 | — | 21.8% |
| 资本支出强度资本支出/营收 | — | 21.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $1.4B |
8季度趋势，按日历期对齐
经营现金流EWRBLX
| Q1 26 | — | — | ||
| Q4 25 | $450.9M | $607.0M | ||
| Q3 25 | $573.7M | $546.2M | ||
| Q2 25 | $290.2M | $199.3M | ||
| Q1 25 | $280.4M | $443.9M | ||
| Q4 24 | $-127.5M | $184.5M | ||
| Q3 24 | $351.8M | $247.4M | ||
| Q2 24 | $371.5M | $151.4M |
自由现金流EWRBLX
| Q1 26 | — | — | ||
| Q4 25 | $353.5M | $308.6M | ||
| Q3 25 | $516.2M | $443.6M | ||
| Q2 25 | $240.9M | $176.7M | ||
| Q1 25 | $224.4M | $426.5M | ||
| Q4 24 | $-177.3M | $120.6M | ||
| Q3 24 | $299.9M | $218.0M | ||
| Q2 24 | $286.1M | $111.7M |
自由现金流率EWRBLX
| Q1 26 | — | — | ||
| Q4 25 | 22.5% | 21.8% | ||
| Q3 25 | 33.2% | 32.6% | ||
| Q2 25 | 15.7% | 16.3% | ||
| Q1 25 | 15.9% | 41.2% | ||
| Q4 24 | -12.8% | 12.2% | ||
| Q3 24 | 22.1% | 23.7% | ||
| Q2 24 | 20.9% | 12.5% |
资本支出强度EWRBLX
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 21.1% | ||
| Q3 25 | 3.7% | 7.5% | ||
| Q2 25 | 3.2% | 2.1% | ||
| Q1 25 | 4.0% | 1.7% | ||
| Q4 24 | 3.6% | 6.5% | ||
| Q3 24 | 3.8% | 3.2% | ||
| Q2 24 | 6.2% | 4.4% |
现金转化率EWRBLX
| Q1 26 | — | — | ||
| Q4 25 | 4.94× | — | ||
| Q3 25 | 1.97× | — | ||
| Q2 25 | 0.87× | — | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | -0.33× | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 1.01× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
